C07F
Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen
Official title: Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium (metal-containing porphyrins c07d487/22)
C07F (Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen) appears on 42,491 US grants and 33,993 published applications in this corpus.
Search patents in C07F- Granted patents
- 42,491
- Published applications
- 33,993
- Assignees
- 8,948
- Inventors
- 70,284
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 888 | 0 |
| 1977 | 718 | 0 |
| 1978 | 879 | 0 |
| 1979 | 541 | 0 |
| 1980 | 633 | 0 |
| 1981 | 686 | 0 |
| 1982 | 490 | 0 |
| 1983 | 498 | 0 |
| 1984 | 529 | 0 |
| 1985 | 619 | 0 |
| 1986 | 546 | 0 |
| 1987 | 585 | 0 |
| 1988 | 556 | 0 |
| 1989 | 645 | 0 |
| 1990 | 637 | 0 |
| 1991 | 730 | 0 |
| 1992 | 761 | 0 |
| 1993 | 805 | 0 |
| 1994 | 735 | 0 |
| 1995 | 726 | 0 |
| 1996 | 836 | 0 |
| 1997 | 910 | 0 |
| 1998 | 923 | 0 |
| 1999 | 836 | 0 |
| 2000 | 807 | 0 |
| 2001 | 891 | 210 |
| 2002 | 866 | 747 |
| 2003 | 733 | 900 |
| 2004 | 623 | 1065 |
| 2005 | 543 | 993 |
| 2006 | 684 | 982 |
| 2007 | 586 | 972 |
| 2008 | 593 | 964 |
| 2009 | 643 | 1098 |
| 2010 | 805 | 1217 |
| 2011 | 789 | 1202 |
| 2012 | 841 | 1138 |
| 2013 | 1051 | 1374 |
| 2014 | 1120 | 1490 |
| 2015 | 1329 | 1653 |
| 2016 | 1283 | 1632 |
| 2017 | 1303 | 1587 |
| 2018 | 1312 | 1649 |
| 2019 | 1367 | 1614 |
| 2020 | 1258 | 1765 |
| 2021 | 1170 | 1645 |
| 2022 | 1062 | 1718 |
| 2023 | 1134 | 1868 |
| 2024 | 1064 | 1797 |
| 2025 | 1119 | 1548 |
| 2026 | 803 | 1165 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Main groups
Granted patents with any code in the group
- C07F 9/00Compounds containing elements of groups 5 or 15 of the periodic table18,170
- C07F 7/00Compounds containing elements of groups 4 or 14 of the periodic table13,372
- C07F 15/00Compounds containing elements of groups 8, 9, 10 or 18 of the5,716
- C07F 5/00Compounds containing elements of groups 3 or 13 of the periodic table4,847
- C07F 17/00Metallocenes2,132
- C07F 1/00Compounds containing elements of groups 1 or 11 of the periodic table1,401
- C07F 3/00Compounds containing elements of groups 2 or 12 of the periodic table1,250
- C07F 13/00Compounds containing elements of groups 7 or 17 of the periodic table745
Recent patents
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- Nanoparticles, dispersion of nanoparticles, and production method of nanoparticles6 Oct 2026US 12,753,087 B2Tokyo Ohka Kogyo.Co., Ltd.
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Organic compound, mixture, composition, and organic electronic device6 Oct 2026US 12,753,191 B2
- Novel phosphoantigen prodrug compound and use thereof8 Oct 2026US 2026/0306541 A1
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Modified Metal-Organic Framework (MOF) Compositions, Process of Making and Process of Use Thereof8 Oct 2026US 2026/0307047 A1NuMat Technologies, Inc.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis and other disorders8 Oct 2026US 2026/0308181 A1Miralogx LLC
Most cited
By later US patents
- Liposomes with enhanced circulation time1,198US 5,013,556 ALiposome Technology, Inc. · 1991
- Polymeric transition metal complexes and uses thereof1,155US 6,605,200 B1TheraSense, Inc. · 2003
- Transition metal complexes with bidentate ligand having an imidazole ring and sensor constructed therewith1,152US 6,605,201 B1TheraSense, Inc. · 2003
- Use of hexahydrolupulones as antibacterial agents1,024US 6,486,286 B1Affymetrix, Inc. · 2002
- Phosphorescent compounds and devices comprising the same1,017US 6,835,469 B2Universal Display Corporation · 2004